Dosage and Administration

Switch to mobile view »

It is advisable to take tinidazole with food to minimize the incidence of epigastric discomfort and other gastrointestinal side-effects. Food does not affect the oral bioavailability of tinidazole (see Clinical Pharmacology). Alcoholic beverages should be avoided when taking tinidazole and for 3 days afterwards (see Drug Interactions).

Bacterial vaginosis

The recommended dose in non-pregnant females is a 1 g oral dose once daily for 5 days taken with food or a 2 g oral dose once daily for 2 days taken with food. The use of tinidazole in pregnant patients has not been studied for bacterial vaginosis.

Two convenient dosing options for BV
2 g/2-day dosing4 x 500 mg tablets once daily for 2 days, taken with food 1 g/5-day dosing2 x 500 mg tablets once daily for 5 days, taken with food
Day 1: 4 x 500 mg Tindamax tablets Day 1: 2 x 500 mg Tindamax tablets
Day 2: 4 x 500 mg Tindamax tablets Day 2: 2 x 500 mg Tindamax tablets
  Day 3: 2 x 500 mg Tindamax tablets
Day 4: 2 x 500 mg Tindamax tablets
Day 5: 2 x 500 mg Tindamax tablets
Table 1

Trichomoniasis

The recommended dose in both females and males is a single 2 g oral dose taken with food. Since trichomoniasis is a sexually transmitted disease, sexual partners should be treated with the same dose and at the same time.

Giardiasis

The recommended dose in adults is a single 2 g dose taken with food. In pediatric patients older than three years of age, the recommended dose is a single dose of 50 mg/kg (up to 2 g) with food.

Amebiasis

Intestinal

The recommended dose in adults is a 2 g dose per day for 3 days taken with food. In pediatric patients older than three years of age, the recommended dose is 50 mg/kg/day (up to 2 g per day) for 3 days with food.

Amebic liver abscess

The recommended dose in adults is a 2 g dose per day for 3-5 days taken with food. In pediatric patients older than three years of age, the recommended dose is 50 mg/kg/day (up to 2 g per day) for 3-5 days with food. There are limited pediatric data on durations of therapy exceeding 3 days, although a small number of children were treated for 5 days without additional reported adverse reactions. Children should be closely monitored when treatment durations exceed 3 days.

Tindamax® dosing recommendations
Indication Adults Children > 3 Years of Age
Trichomoniasis 2 g single dose* n/a
Giardiasis 2 g single dose 50 mg/kg single dose
(up to 2 g)
Intestinal Amebiasis 2 g QD
× 3 days
50 mg/kg QD
× 3 days
(up to 2 g/day)
Amebic Liver Abscess 2 g QD
× 3-5 days
50 mg/kg QD
× 3-5 days
(up to 2 g/day)

* Treat sexual partners with the same dose and at the same time.

Please see full Prescribing Information.

Table 2

Compounding of the oral suspension

For those unable to swallow tablets, tinidazole tablets may be crushed in artificial cherry syrup to be taken with food.

Procedure for compounding of the oral suspension

Pulverize four 500 mg oral tablets with a mortar and pestle. Add approximately 10 mL of cherry syrup to the powder and mix until smooth. Transfer the suspension to a graduated amber container. Use several small rinses of cherry syrup to transfer any remaining drug in the mortar to the final suspension for a final volume of 30 mL. The suspension of crushed tablets in artificial cherry syrup is stable for 7 days at room temperature. When this suspension is used, it should be shaken well before each administration.

Important Safety Information

WARNING: POTENTIAL RISK FOR CARCINOGENICITY

Carcinogenicity has been seen in mice and rats treated chronically with metronidazole, another nitroimidazole agent. Although such data have not been reported for tinidazole, the two drugs are structurally related and have similar biologic effects. Its use should be reserved for the conditions described in INDICATIONS AND USAGE.

Contraindications

  • Prior history of hypersensitivity to tinidazole or other nitroimidazole derivatives
  • First trimester of pregnancy
  • Nursing mothers, unless breast-feeding is interrupted during tinidazole therapy and for 3 days following the last dose

Warnings and Precautions

  • Seizures and neuropathy have been reported. Discontinue Tindamax if abnormal neurologic signs develop
  • Vaginal candidiasis may develop with Tindamax and require treatment with an antifungal agent
  • Use Tindamax with caution in patients with blood dyscrasias. Tindamax may produce transient leukopenia and neutropenia

Adverse Reactions

Most common adverse reactions for a single 2 g dose of tinidazole (incidence >1%) are metallic/bitter taste, nausea, weakness/fatigue/malaise, dyspepsia/cramps/epigastric discomfort, vomiting, anorexia, headache, dizziness and constipation. To report SUSPECTED ADVERSE REACTIONS, contact Mission Pharmacal Company at 1-800-298-1087 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

This material is intended to provide basic information. Patients should discuss all medical advice, diagnosis, and treatment with their healthcare provider.

Please see full Prescribing Information


Only Tindamax® is approved to treat both bacterial vaginosis and trichomoniasis (TV).

Clinical Insight

Oral vs vaginal cream therapy: Patient preference for oral dosing is demonstrated to be 84%. More»

Beyond BV

Tindamax® may be prescribed for other infections including: